LMNA and breast carcinoma: Western blot analysis showed that treatment of human breast cancer MDA-MB-231 and MCF-7 cells with doxorubicin decreased the levels of lamin A/C in the nucleus in a dose- and time-dependent manner, but had little effect on the expression of lamin A/C in whole cellular extracts, suggesting that DNA damage may promote degradation of lamin A/C.